TCM Biotech International Corp. (TPEX:4169)
Taiwan · Delayed Price · Currency is TWD 126.50
+6.50 (5.42%)
Oct 9, 2025, 2:59 PM CST
TCM Biotech International Market Cap
TCM Biotech International has a market cap or net worth of 7.47 billion as of October 10, 2025. Its market cap has increased by 110.83% in one year.
Market Cap
7.47B
Enterprise Value
6.98B
Revenue
674.43M
Ranking
n/a
PE Ratio
276.55
Stock Price
126.50
Market Cap Chart
Since May 7, 2012, TCM Biotech International's market cap has increased from 1.37B to 7.47B, an increase of 446.03%. That is a compound annual growth rate of 13.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 7.47B | 118.48% |
| Dec 31, 2024 | 3.42B | -0.52% |
| Dec 29, 2023 | 3.44B | 128.87% |
| Dec 30, 2022 | 1.50B | -17.43% |
| Dec 30, 2021 | 1.82B | 6.17% |
| Dec 31, 2020 | 1.71B | 62.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 198.23B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |